Preclinical CRO Market Size, Bridging Discovery and Clinical Trials
According to market projections, the preclinical CRO sector is expected to grow from USD 6.25 billion in 2024 to USD 14.34 billion by 2034, reflecting a CAGR of 8.73%. In 2024, North America led the preclinical CRO market with a 48% share, while Asia Pacific is set for the fastest growth through 2034. Toxicology testing dominated by service, while bioanalysis & DMPK studies are growing fastest. PDO models led by type, and PDXs are set for strong expansion. Biopharma led in end-use, with government & academia growing fastest.
Last Updated : 21 April 2026
Category: Healthcare Services
Insight Code: 5442
Format: PDF / PPT / Excel